Literature DB >> 2425623

Morphology and incidence of the "posttherapeutic lymphoid cell" in the bone marrow of children with acute lymphoblastic leukemia.

J H Schuurmans Stekhoven, C A Langenhuysen, J A Bakkeren, R Holland, I Höller, G A De Vaan, E D Schretlen.   

Abstract

In the posttherapeutic bone marrow of a group of 30 children with acute lymphoblastic leukemia (ALL), small numbers of a particular lymphoid cell with a comparatively large size and large dark nucleus were found. This cell was called the "posttherapeutic lymphoid cell." This type of cell is easily distinguishable in the May-Grünwald-Giemsa-stained smears as well as in semi- and ultrathin Epon sections. Immunoelectron-microscopically it proved to be positive for common ALL. It is hypothesized that the cell might be characteristic for ALL. However, it appeared that this cell could equally be found in non-Hodgkin's malignant lymphoma after a treatment comparable to that in ALL. Furthermore, the cell could be detected in the posttherapeutic bone marrow of children with nonlymphoid malignancies as well as the marrow of very young children (under 2 years of age) with nonmalignant diseases. The results showed that the cell in question is not associated with a particular disease but, rather, represents a special type of lymphoid cell in the regenerating or actively proliferating bone marrow.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2425623      PMCID: PMC1888181     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  8 in total

1.  [T and B lymphocytes before, during, and after cytostatic therapy of acute lymphoblastic leukemia (ALL) in children (author's transl)].

Authors:  H Wehinger; D Karitzky
Journal:  Klin Padiatr       Date:  1977-05       Impact factor: 1.349

2.  Nuclear pockets and clefts in the lymphoid cell population of bone marrow and blood of children with acute lymphoblastic leukemia.

Authors:  J H Schuurmans Stekhoven; R Holland
Journal:  Am J Pathol       Date:  1986-07       Impact factor: 4.307

3.  Acute lymphoblastic leukaemia associated antigen. IV. Expression on non-leukaemic 'lymphoid' cells.

Authors:  M Greaves; D Delia; G Janossy; N Rapson; J Chessells; M Woods; G Prentice
Journal:  Leuk Res       Date:  1980       Impact factor: 3.156

4.  Immunological rebound after cessation of long-term chemotherapy in acute lymphocytic leukaemia: changes in distribution of T and B cell populations in bone marrow and peripheral blood.

Authors:  L Sen; L Borella
Journal:  Br J Haematol       Date:  1974-07       Impact factor: 6.998

5.  Immunologic rebound after cessation of long-term chemotherapy in acute leukemia.

Authors:  L Borella; A A Green; R G Webster
Journal:  Blood       Date:  1972-07       Impact factor: 22.113

6.  Interrelationship of immunologic characteristics, proliferation pattern, and prednisone sensitivity in acute lymphoblastic leukemia of childhood.

Authors:  J A Bakkeren; G A de Vaan; H F Hillen
Journal:  Blood       Date:  1979-05       Impact factor: 22.113

7.  Pre-B and B cells in children on leukaemia remission maintenance treatment.

Authors:  P Paolucci; A R Hayward; N T Rapson
Journal:  Clin Exp Immunol       Date:  1979-08       Impact factor: 4.330

8.  Recovery of immune function after cessation of maintenance therapy in acute lymphoblastic leukemia (ALL) of childhood.

Authors:  G A de Vaan; P J van Munster; J A Bakkeren
Journal:  Eur J Pediatr       Date:  1982-10       Impact factor: 3.183

  8 in total
  1 in total

1.  Impact of bone marrow hematogones on umbilical cord blood transplantation outcomes in patients with acute myeloid leukemia.

Authors:  Theodore Honebrink; Vanessa Dayton; Michael J Burke; Karen Larsen; Qing Cao; Claudio Brunstein; Daniel Weisdorf; Jeffery S Miller; John E Wagner; Michael R Verneris
Journal:  Biol Blood Marrow Transplant       Date:  2011-11-20       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.